Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia
Conditions
- Chronic Lymphocytic Leukemia
Interventions
- DRUG: Lenalidomida and Rituximab
Sponsor
MD Anderson International Spain SA
Collaborators